Please sign up or log in to continue.
Devpost
Participate in our public hackathons
Devpost for Teams
Access your company's private hackathons
Grow your developer ecosystem and promote your platform
Drive innovation, collaboration, and retention within your organization
By use case
Blog
Insights into hackathon planning and participation
Customer stories
Inspiration from peers and other industry leaders
Planning guides
Best practices for planning online and in-person hackathons
Webinars & events
Upcoming events and on-demand recordings
Help desk
Common questions and support documentation
Accuracy in every move
Reversing drug discovery to unlock rare disease treatments from deprioritized and generic drugs.
Don't get knocked out
AI-Powered Rare Disease Drug Repurposing Engine
Turning flare chaos into clear action
EXtracting expliciti exclusions
Integrated platform that identifies optimal gene-therapy strategies for rare diseases and automatically generates supporting experimental assays and research protocols for validation.
Gene-ie transforms genes into treatment leads — using GNN intelligence and structured LLM reasoning to deliver transparent, safety-aware drug repurposing for rare diseases.
Diageno is your Next-Best-Step Diagnostic Copilot tool that utilizes patient HPO, phenotype, genotype, and declassified medical data to give informed next steps and potential diagnoses.
Your symptoms, finally heard.
Multimodal Diagnostic Copilot for Rare Neurological Disorders
We aim to streamline the rare disease treatment identification process. Input your disease and receive a collection of the most common CRISPR-targetable mutations. Skip deep searching; meet snoBANK.
Flare prediction | Digital Biomarker | Gamification
A patient diagnosed with a specific exon deletion today still relies on a geneticist manually cross-referencing literature and databases to determine if exon skipping helps. Becker makes it easy.
OriGen resolves previously undiagnosed rare disease cases by interpreting genetic variants through protein structure and molecular mechanism, overcoming data scarcity and functional uncertainty.
The 5-sec voice sample is analyzed by AI to identify the presence of vocal fatigue patterns, which are associated with MG, and translate the imperceptible changes in pitch and breath to a risk score.
We built a rare disease platform that ranks repurposing drugs with clear evidence and uncertainty. Validated on known therapies and FDA labels also finds new targets when no options exist
Engineering Endpoints for Tiny Cohorts
This is Amelie, a personalized health companion built specifically for rare disease patients.
A steady voice when the road feels uncertain
Platform for Recurrent Respiratory Papillomatosis that matches similar patient profiles to aggregate real-world therapeutic outcomes and support evidence-guided care decisions.
CareConsole.ai — Your health baseline. Your early warning system.
PRANA is a patient companion for rare diseases that lets patients set their own life goals, tracks their symptoms.
ReScore prioritizes unsolved genetic cases for reanalysis by scoring evolving phenotypes, new evidence, and testing blind spots — directing clinicians to cases most likely to yield a diagnosis
1 – 24 of 42
